Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

Cognitive Intervention for Persons With Amnestic Mild Cognitive Impairment

13. mars 2019 oppdatert av: National Taiwan University Hospital

Cognitive Intervention for Persons With Amnestic Mild Cognitive Impairment: The Efficacy in Enhancement of Cognition and Complex Activities of Daily Living Function

People with mild cognitive impairment (MCI) are at a greater risk of developing dementia. Therefore, it is important to develop effective non-pharmacological interventions to facilitate their cognitive and activities of daily living (ADL) function, which will also prevent or delay their progression to dementia and reduce associated healthcare and social costs. There are currently a variety of cognitive interventions, mainly categorized as remediation and rehabilitation approach. Research to compare their contents and effectiveness is strongly needed. The information can be used to individualize cognitive intervention based on specific cognitive profile of the patient.

This study aims to determine the immediate and long-term efficacy of the remediation approach and rehabilitation approach in enhancing the cognitive and ADL function. The research questions include 1) whether the rehabilitation approach compared with the remediation approach has better effects on improving ADL function; (2) whether the remediation approach may only enhance the performance on the cognitive tests rather than on the ADL function. This study will also explore whether the attitudes of caregivers on providing ADL assistance affect effects of cognitive intervention.

Studieoversikt

Detaljert beskrivelse

The study is designed by a single-blinded randomized control trial. Sixty persons with MCI, confirmed by physicians, will receive 12 weekly 90-minute cognition interventions in a group of 6-8 persons. All participants will be randomly assigned to the following groups: 1) Remediation approach: various cognitive strategies will be taught, and exercises involving the practice of these strategies to enhance the attention, memory, processing speed, and executive functions. 2) Combination of rehabilitation and remediation approaches: The first half of each session will focus on the remediation approach as described above. The second half of the session will apply rehabilitation approach. The investigators will use group discussion to discuss everyday situations with memory problem and specific strategies (internal and external) related to real-life situations. The investigators will also include one individual session in the 12 group sessions.

All participants will be assessed at 3 time points: before intervention, right after intervention, and 12 weeks after the intervention. The primary outcomes are the ADL functions evaluated by subjective and objective measures, and cognitive function evaluated by tests of attention, memory and executive function. The secondary outcomes include the depression, the quality of life of the participants, and the caregivers' load. The intervention effects will be further analyzed by the caregivers' attitude regarding to the level of ADL assistance.

Studietype

Intervensjonell

Registrering (Faktiske)

40

Fase

  • Ikke aktuelt

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiesteder

      • Taipei, Taiwan, 100
        • National Taiwan University Hospital

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

50 år og eldre (Voksen, Eldre voksen)

Tar imot friske frivillige

Nei

Kjønn som er kvalifisert for studier

Alle

Beskrivelse

Criteria: Inclusion Criteria:

  • over 50 years old
  • years of education > 6
  • mild cognitive impairment diagnosed by physician
  • no dementia diagnosis
  • Barthel Index scored 100
  • Geriatric Depression Scale-Short Form scored < 8

Exclusion Criteria:

  • without concurrent major or significant psychiatric disorders
  • severe physical diseases which might affect cognitive functions
  • difficult to follow instructions due to visual or hearing impairments

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Primært formål: Helsetjenesteforskning
  • Tildeling: Randomisert
  • Intervensjonsmodell: Parallell tildeling
  • Masking: Enkelt

Våpen og intervensjoner

Deltakergruppe / Arm
Intervensjon / Behandling
Eksperimentell: rehabilitation & remediation approach
The intervention group will receive 12 weekly 90-minute combined cognition interventions in a group. The first half of each session will be cognitive training which focus on teaching various cognitive strategies and their applications to enhance the attention, memory, processing speed, and executive functions. The second half of the session will apply rehabilitation intervention with various compensatory strategies. Investigators will use group discussion to discuss everyday situations with memory problem and specific strategies (internal and external) related to real-life situations. Investigators will also include one individual session in the 12 group sessions.
The rehabilitation & remediation approach group will receive 12 weekly 90-minute combined cognition interventions in a group. The first half of each session will be cognitive training which focus on teaching various cognitive strategies to enhance the attention, memory, processing speed, and executive functions. The second half of the session will apply rehabilitation intervention by discussing everyday situations with memory problem and specific strategies related to real-life situations. Investigators will also include one individual session in the 12 group sessions.
Aktiv komparator: remediation approach
The remediation approach will receive 12 weekly 90-minute cognitive training which focus on teaching various cognitive strategies and their applications to enhance the attention, memory, processing speed, and executive functions.
The remediation approach will receive 12 weekly 90-minute cognitive training which focus on teaching various cognitive strategies and their applications to enhance the attention, memory, processing speed, and executive functions.

Hva måler studien?

Primære resultatmål

Resultatmål
Tidsramme
Change from Baseline The Brief University of California San Diego (UCSD) Performance-Based Skills Assessment (Traditional Chinese Version)(UPSA-Brief ) at the 12th and 24th weeks
Tidsramme: baseline, 12th and 24th weeks after intervention
baseline, 12th and 24th weeks after intervention

Sekundære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Change from Baseline Short-form Zarit Caregiver Burden Interview-12 (sCZBI-12) at the 12th and 24th weeks
Tidsramme: baseline, 12th and 24th weeks after intervention
baseline, 12th and 24th weeks after intervention
Change from Baseline Montreal Cognitive Assessment (MoCA) Taiwan Version at the 12th and 24th weeks
Tidsramme: baseline, 12th and 24th weeks after intervention
baseline, 12th and 24th weeks after intervention
Change from Baseline Word Sequence Learning Test at the 12th and 24th weeks
Tidsramme: baseline, 12th and 24th weeks after intervention
baseline, 12th and 24th weeks after intervention
Change from Baseline Minimal-Mental Status Exam (MMSE) at the 12th and 24th weeks
Tidsramme: baseline, 12th and 24th weeks after intervention
baseline, 12th and 24th weeks after intervention
Change from Baseline Miami Prospective Memory Test (MPMT) at the 12th and 24th weeks
Tidsramme: baseline, 12th and 24th weeks after intervention
baseline, 12th and 24th weeks after intervention
Change from Baseline Color Trails Test at the 12th and 24th weeks
Tidsramme: baseline, 12th and 24th weeks after intervention
baseline, 12th and 24th weeks after intervention
Change from Baseline Structure MRI at the 12th and 24th weeks
Tidsramme: baseline, 12th and 24th weeks after intervention
baseline, 12th and 24th weeks after intervention
Change from Baseline PiB-PET and FDG-PET at the 12th and 24th weeks
Tidsramme: baseline, 12th and 24th weeks after intervention
PiB-PET: Pittsburgh Compound B-Positron Emission Tomography FDG-PET:18-Fluoro-deoxyglucose positron emission tomography
baseline, 12th and 24th weeks after intervention
Change from Baseline amyloid Aβ40, Aβ42 and tau proteins at the 12th and 24th weeks
Tidsramme: baseline, 12th and 24th weeks after intervention
baseline, 12th and 24th weeks after intervention
Change from Baseline The Disability Assessment for Dementia (DAD) at the 12th and 24th weeks
Tidsramme: baseline, 12th and 24th weeks after intervention
baseline, 12th and 24th weeks after intervention
Change from Baseline Quality of Life-Alzheimer's Disease scale (QoL-AD) at the 12th and 24th weeks
Tidsramme: baseline, 12th and 24th weeks after intervention
baseline, 12th and 24th weeks after intervention
Change from Baseline Goal Attainment Scaling (GAS) at the 12th and 24th weeks
Tidsramme: baseline, 12th and 24th weeks after intervention
baseline, 12th and 24th weeks after intervention
Change from Baseline Everyday Memory Questionnaire at the 12th and 24th weeks
Tidsramme: baseline, 12th and 24th weeks after intervention
baseline, 12th and 24th weeks after intervention

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Etterforskere

  • Hovedetterforsker: Hui-Fen Mao, National Taiwan University Hospital

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Faktiske)

16. desember 2014

Primær fullføring (Faktiske)

14. november 2017

Studiet fullført (Faktiske)

14. november 2017

Datoer for studieregistrering

Først innsendt

18. mai 2016

Først innsendt som oppfylte QC-kriteriene

24. mai 2016

Først lagt ut (Anslag)

27. mai 2016

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

14. mars 2019

Siste oppdatering sendt inn som oppfylte QC-kriteriene

13. mars 2019

Sist bekreftet

1. mars 2019

Mer informasjon

Begreper knyttet til denne studien

Andre studie-ID-numre

  • 201402028RINC

Plan for individuelle deltakerdata (IPD)

Planlegger du å dele individuelle deltakerdata (IPD)?

NEI

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Abonnere